Floatz logo

Emunkitug

Testicular Germ Cell Tumor

HiFiBiO Therapeuticsmonoclonal_antibodyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Testicular Germ Cell Tumor cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
City of Hope Medical Center
Phase 2BBB
FILGRASTIM
University of Southampton
Phase 2BBB
Carboplatin
City of Hope Medical Center
Phase 2BBB
Ifosfamide
City of Hope Medical Center
Phase 2BBB
Cyclophosphamide
Barbara Ann Karmanos Cancer Institute
Phase 2BB

View all 48 →

Same molecule, other indications

Emunkitug is also rated in:

sarcomaDormant
C
Indicative ·
39 / 100
View asset →
mesotheliomaDormant
C
Indicative ·
39 / 100
View asset →
melanomaDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →